In the rat heart with STZ-induced diabetes, FoxO1 overactivation was found to shift substrate selection from glucose to fatty acid, induce disarranged oxidative metabolism, mitochondrial dysfunction and cardiomyocyte apoptosis, and ultimately cause cardiac dysfunction 37. Here, FOXO1 is linked to diabetes mellitus.